IP Library Patent Application 11315036
Patent Application
App. No. 11/315,036

cGMP-binding, cGMP-specific phosphodiesterase materials and methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/315,036
Abstract

The present invention provides novel purified and isolated nucleotide sequences encoding the cGMP-binding, cGMP-specific phosphodiesterase designated cGB-PDE. Also provided by the invention are methods and materials for the recombinant production of cGB-PDE polypeptide products and methods for identifying compounds which modulate the enzymatic activity of cGB-PDE polypeptides.

Claims (21)

1 . A purified and isolated polynucleotide encoding cGB-PDE.

2 . The polynucleotide of claim 1 which is a DNA sequence.

3 . The DNA sequence of claim 2 which is a cDNA sequence or a biological replica thereof.

4 . The DNA sequence of claim 2 which is a genomic DNA sequence or a biological replica thereof.

5 . An RNA transcript of the genomic DNA sequence of claim 4 .

6 . The DNA sequence of claim 2 which is a wholly or partially chemically synthesized DNA sequence or a biological replica thereof.

7 . The DNA sequence of claim 4 further comprising an endogenous expression control DNA sequence.

8 . A DNA vector comprising a DNA sequence according to claim 2 .

9 . The vector of claim 8 wherein said DNA sequence is operatively linked to an expression control DNA sequence.

10 . A host cell stably transformed or transfected with a DNA sequence according to claim 7 in a manner allowing the expression in said host cell of cGB-PDE polypeptide possessing a ligand/receptor binding biological activity or immunological property specific to cGB-PDE.

11 . A method for producing cGB-PDE polypeptide, said method comprising growing a host cell according to claim 10 in a suitable nutrient medium and isolating cGB-PDE polypeptide from said cell or the medium of its growth.

12 . A polypeptide or peptide capable of specifically binding to cGB-PDE.

13 . An antibody substance according to claim 12 .

14 . A monoclonal antibody according to claim 13 .

15 . A hybridoma cell line producing a monoclonal antibody according to claim 14 .

16 . A humanized antibody substance according to claim 13 .

17 . An antisense polynucleotide specific for a polynucleotide encoding cGB-PDE.

18 . A DNA sequence encoding cGB-PDE and selected from the group consisting of:

(a) the DNA sequence set out in SEQ ID NO: 9 or 22;

(b) a DNA which hybridizes under stringent conditions to the DNA of (a); and

(c) a DNA sequence which, but for the redundancy of the genetic code, would hybridize under stringent conditions to a DNA sequence of (a) or (b).